TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Incidence of pressure sores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of eligible clients initiating DAAs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of complete treated clients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of SVR achieved clients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neurodevelopmental development
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Gut microbiome changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hard stool consistency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Painful defecation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of participants recruited and ended intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of participants accepting the CWH intervention as helpful
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Blood concentration of bisdemethoxycurcumin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Blood concentration of desmethoxycurcumin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Blood concentration of piperine-curcuminoids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Blood concentration of hexahydrocurcumin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Blood concentration of curcumin diethyl disuccinate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in Procedure-Related Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Area under ROC curve of risk factors for aspergillus pneumonia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Crompehension Complexity Index (CCI)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: blood lipid profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: liver characteristics profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage wound area reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Plasma NGAL Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urine NGAL Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hamstrings flexibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Robotic surgery simulator score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numerical Evaluation Scale-Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Medical Research Council Dyspnea Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Multidimensional Assessment of Fatigue Scale
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Trial adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Willingness to Accept Medical Advice
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Willingness to Participate in a Clinical Trial
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Education Perception
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Occupation Perception
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Count of respiratory particles emitted
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Vascular Area Density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Vascular Fractal Dimension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Vascular Orientation Distribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: postoperative all cause mortality
Endpoint domain: Mortality/survival
Primary endpoint: major composite morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hearing in noise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective effects of alcohol
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Menstrual hygiene and well-being
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Right renal artery mean blood velocities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CPR Skill Retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of adverse clinical, laboratory, or immunological responses
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in viral load in infants found to be HIV infected
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Changes in the slope of absolute CD4 counts in all immunized children
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: New bone growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Absence of serious device related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Post-operative venous thromboembolism
Endpoint domain: Adverse events/effects
Primary endpoint: risk stratification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: impact of risk stratification on CAD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: platelet function as measured by aperture closure time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: postoperative Catquest-9SF score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Delta in AMH levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Incidence of infusion related reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in BOLD response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in a. cerebri media diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Changes in CBF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Number of Participants with Evidence of Inflammatory Alterations in the Gastrointestinal Tract
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Adverse Events by type, frequency, and severity
Endpoint domain: Adverse events/effects
Primary endpoint: Feasibility of SLN(s) or lymph node metastases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of SLN(s) or lymph node metastases
Endpoint domain: Adverse events/effects
Primary endpoint: Mean change in maximal voluntary isometric force of the knee extensors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Serum anti-Mullerian hormone (AMH) level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Matrix metalloproteinase-9 gene polymorphism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Voiding Disorders Symptom Scoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bladder and Bowel Dysfunction Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pediatric İncontinence Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Distribution Volume Ratio (DVR) of [11C]MRB PET Imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Microneurography (Muscle Sympathetic Nerve Activity (MSNA)) Measured by Burst Frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Patient- or caregiver-filled questionnaires
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: functional connectivity measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of hypoparathyroidism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Incidence of silent cerebral embolism (SCE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: change of bone marrow edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BFI score change
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change in Adapted International Prostate Symptom Score (IPSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: buprenorphine uptake
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: buprenorphine adherence
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Binge drinking score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Rey Auditory Verbal Learning Test (RAVLT) Total Recall
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Dual Task Cost to Gait
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attendance at baseline colposcopy appointment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Multidimensional Caregiver Strain Index
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: Change in Perceived Stress Scale score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in EQ-5D-5L scale score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: EASI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: DQLI
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Itch Numerical Rating Scale (NRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Range of Motion in Degrees
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comfort Perception Scale in Oral Mucositis
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Oral Mucositis Grading Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blastocyst ploidy status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Dementia Rating Scale (CDRS)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Occurrence of postoperative complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of tissue samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uroflowmetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postmicturition residue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retrograde Urethrogram (RUG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time to Maximum (Peak) Plasma Concentration (Tmax) of Emraclidine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-time Curve From Time 0 to the Time of Last Quantifiable Concentration (AUC0-t) of Emraclidine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-time Curve From Time 0 Extrapolated to Infinity (AUC0-inf) of Emraclidine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants with Abdominal Wall Dehiscence
Endpoint domain: Adverse events/effects
Primary endpoint: Accuracy of sound localization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time intervals of the prehospital transportation process
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: L-DOPA challenge completion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FSPI Completion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Measure Completion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Stress level change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in tau PET Standardized Uptake Value (SUVR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Gain of horizontal bone thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non-inferiority of the LIFT System compared to TTO
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in physical deconditioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the levels of anti-cancer factors in blood plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of participants with REM sleep behavior disorder (RBD)
Endpoint domain: Adverse events/effects
Primary endpoint: Sensitivity of RT-PCR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Specificity of RT-PCR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders-5 (PCL-5)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction in incidence of HIV and or Chlamydia and or Gonorrhoeae
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Reduction in acts of intimate partner violence
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Lower proportion of those who have reduced endorsement of intimate partner violence supportive attitudes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: defecation behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: O-GlcNAcylation levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: American spinal cord injury association impairment scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sollerman hand function test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Jamar pinchmeter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of MINS
Endpoint domain: Adverse events/effects
Primary endpoint: Intestinal flora difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of Columnar lined epithelium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in proportion of patients that receive a vaccine recommendation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in self-reported rate of patient vaccine uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative biopsy rate 24 months post-treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Serious toxicity rate 24 months post-treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of sudden cardiac death or sustained ventricular tachycardia
Endpoint domain: Mortality/survival
Primary endpoint: Vineland Adaptive Behavior Scales-Third Edition
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Functional Emotional Assessment Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Serum S protein-specific binding antibody concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum SARS-CoV-2 specific neutralizing antibody titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of viable specimens for laboratory analysis
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Prevention of Hair Loss
Endpoint domain: Adverse events/effects
Primary endpoint: Child Emotional and Behavioral Disorders
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mindfulness in Children and Adolescents
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Optimism in Children and Adolescents
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in force parameters (Newton)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Velocity (m/s)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Five Times Sit to Stand test time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: % time below range (<70 mg/dL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Level 1 (<70 mg/dL) and Level 2 (<54 mg/dL) hypoglycemic events
Endpoint domain: Adverse events/effects
Primary endpoint: SpO2>80
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Joint pain visual analog scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of machine learning model
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-Management behaviors
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Maxillomandibular sagittal changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vertical changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight-for-Age Z score (WAZ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: early feeding skills assessment
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: parenting stress index, fourth edition short form
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Fugl-Mayer Upper limb assessment (FMA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wolf motor function test (WMT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: box and blocks test (BBT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under curve (AUC) of change in total lower respiratory tract symptoms (LRTS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Post-operative lung consolidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Body Mass Index z - score (BMIz)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adverse events and complication
Endpoint domain: Adverse events/effects
Primary endpoint: Cmax: Maximum concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-t: Area under the plasma concentration-time curve from the start of administration to the last measurable concentration time point T
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-inf: Area under the plasma concentration-time curve from the start of administration to infinity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microscopic picture of muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of patients who decide to join in a chronic fatigue syndrome clinical trial
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of chronic fatigue syndrome patients who remain in clinical trial until completion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: frequency of mutations of genes from leptin melanocortin pathway
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Likert stiffness scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of participants with active COVID-19
Endpoint domain: Mortality/survival
Primary endpoint: Change in end-expiratory lung impedance (Delta EELZ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in distribution of lung ventilation (Delta Z)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Prevalence of severe forms (grade II, III)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Long Term Rectal Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Long Term Urinary Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: 4C mortality score
Endpoint domain: Mortality/survival
Primary endpoint: Scores of exhaustion
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Scores of depersonalization
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing